2-Amino-4-methylthiazole → (2-Methyl-5-pyridin-3-yl-[1,7]naphthyridin-8-yl)-(4-methyl-thiazol-2-yl)-amine
反応式
Cl[C:2]1[N:3]=[CH:4][C:5](I)=[C:6]2[C:11]=1[N:10]=[C:9]([CH3:12])[CH:8]=[CH:7]2.[N:14]1[CH:19]=[CH:18][CH:17]=[C:16](B(O)O)[CH:15]=1.[NH2:23][C:24]1[S:25][CH:26]=[C:27]([CH3:29])[N:28]=1>>[CH3:12][C:9]1[CH:8]=[CH:7][C:6]2[C:11](=[C:2]([NH:23][C:24]3[S:25][CH:26]=[C:27]([CH3:29])[N:28]=3)[N:3]=[CH:4][C:5]=2[C:16]2[CH:15]=[N:14][CH:19]=[CH:18][CH:17]=2)[N:10]=1参加物
4
実験手順
The title compound, MS: m/e=334.2 (M+H+), was prepared in accordance with the general method of example 15 step 1 and step 3 from 8-chloro-5-iodo-2-methyl-[1,7]naphthyridine (Example I), 3-pyridineboronic acid and 2-amino-4-methylthiazole.
出典と根拠
- ORDレコード
- ord-cac6be2d6fc7493b92cebf7e16bb87d5
- 出典データセット
- uspto-grants-2009_03
- 特許番号
- US07511055B2
反応ノート
読み込み中…